0001035267-23-000105.txt : 20230424 0001035267-23-000105.hdr.sgml : 20230424 20230424200145 ACCESSION NUMBER: 0001035267-23-000105 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230421 FILED AS OF DATE: 20230424 DATE AS OF CHANGE: 20230424 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: RUBASH MARK J CENTRAL INDEX KEY: 0001209186 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-30713 FILM NUMBER: 23841330 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: INTUITIVE SURGICAL INC CENTRAL INDEX KEY: 0001035267 STANDARD INDUSTRIAL CLASSIFICATION: ORTHOPEDIC, PROSTHETIC & SURGICAL APPLIANCES & SUPPLIES [3842] IRS NUMBER: 770416458 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 1020 KIFER ROAD CITY: SUNNYVALE STATE: CA ZIP: 94086 BUSINESS PHONE: 4085232100 MAIL ADDRESS: STREET 1: 1020 KIFER ROAD CITY: SUNNYVALE STATE: CA ZIP: 94086 4 1 edgardoc.xml PRIMARY DOCUMENT X0407 4 2023-04-21 0 0001035267 INTUITIVE SURGICAL INC ISRG 0001209186 RUBASH MARK J 1020 KIFER ROAD SUNNYVALE CA 94086 1 0 0 0 0 Common Stock 2023-04-21 4 M 0 463 90.4944 A 15463 D Common Stock 2023-04-21 4 S 0 463 297.8943 D 15000 D Common Stock 2023-04-21 4 M 0 173 71.3233 A 15173 D Common Stock 2023-04-21 4 S 0 173 297.8943 D 15000 D Common Stock 2023-04-21 4 M 0 349 71.3233 A 15349 D Common Stock 2023-04-21 4 S 0 349 297.9281 D 15000 D Common Stock 2023-04-21 4 M 0 349 71.3233 A 15349 D Common Stock 2023-04-21 4 S 0 349 297.9443 D 15000 D Common Stock 2023-04-21 4 M 0 349 71.3233 A 15349 D Common Stock 2023-04-21 4 S 0 349 297.9402 D 15000 D Non-Qualified Stock Option (right to buy) 71.3233 2023-04-21 4 M 0 173 0.0 D 2026-04-21 Common Stock 173 1570 D Non-Qualified Stock Option (right to buy) 71.3233 2023-04-21 4 M 0 349 0.0 D 2026-04-21 Common Stock 349 1221 D Non-Qualified Stock Option (right to buy) 71.3233 2023-04-21 4 M 0 349 0.0 D 2026-04-21 Common Stock 349 872 D Non-Qualified Stock Option (right to buy) 71.3233 2023-04-21 4 M 0 349 0.0 D 2026-04-21 Common Stock 349 523 D Non-Qualified Stock Option (right to buy) 90.4944 2023-04-21 4 M 0 927 0.0 D 2027-04-20 Common Stock 927 3708 D Non-Qualified Stock Option (right to buy) 90.4944 2023-04-21 4 M 0 927 0.0 D 2027-04-20 Common Stock 927 2781 D Non-Qualified Stock Option (right to buy) 90.4944 2023-04-21 4 M 0 927 0.0 D 2027-04-20 Common Stock 927 1854 D Non-Qualified Stock Option (right to buy) 90.4944 2023-04-21 4 M 0 463 0.0 D 2027-04-20 Common Stock 463 1391 D Non-Qualified Stock Option (right to buy) 154.2367 2023-04-21 4 M 0 598 0.0 D 2028-04-19 Common Stock 598 2390 D Non-Qualified Stock Option (right to buy) 154.2367 2023-04-21 4 M 0 598 0.0 D 2028-04-19 Common Stock 598 1792 D Non-Qualified Stock Option (right to buy) 154.2367 2023-04-21 4 M 0 598 0.0 D 2028-04-19 Common Stock 598 1194 D Non-Qualified Stock Option (right to buy) 154.2367 2023-04-21 4 M 0 299 0.0 D 2028-04-19 Common Stock 299 895 D Non-Qualified Stock Option (right to buy) 171.0733 2023-04-21 4 M 0 460 0.0 D 2030-04-23 Common Stock 460 1838 D Non-Qualified Stock Option (right to buy) 171.0733 2023-04-21 4 M 0 460 0.0 D 2030-04-23 Common Stock 460 1378 D Non-Qualified Stock Option (right to buy) 171.0733 2023-04-21 4 M 0 460 0.0 D 2030-04-23 Common Stock 460 918 D Non-Qualified Stock Option (right to buy) 171.0733 2023-04-21 4 M 0 230 0.0 D 2030-04-23 Common Stock 230 688 D Non-Qualified Stock Option (right to buy) 172.5933 2023-04-21 4 M 0 472 0.0 D 2029-04-25 Common Stock 472 1886 D Non-Qualified Stock Option (right to buy) 172.5933 2023-04-21 4 M 0 472 0.0 D 2029-04-25 Common Stock 472 1414 D Non-Qualified Stock Option (right to buy) 172.5933 2023-04-21 4 M 0 472 0.0 D 2029-04-25 Common Stock 472 942 D Non-Qualified Stock Option (right to buy) 172.5933 2023-04-21 4 M 0 235 0.0 D 2029-04-25 Common Stock 235 707 D These shares were sold in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on February 1, 2024. The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $296.45 to $299.15 as follows: 275 shares sold at $296.45 to $297.41; 888 shares sold at $297.48 to $298.48; and 237 shares sold at $298.50 to $299.15. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote. The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $296.62 to $299.27 as follows: 638 shares sold at $296.62 to $297.49; 1,718 shares sold at $297.68 to $298.67; and 450 shares sold at $298.69 to $299.27. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote. The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $296.60 to $299.28 as follows: 638 shares sold at $296.60 to $297.51; 1,768 shares sold at $297.72 to $298.69; and 400 shares sold at $298.74 to $299.28. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote. The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $296.60 to $299.27 as follows: 638 shares sold at $296.60 to $297.49; 1,768 shares sold at $297.73 to $298.69; and 400 shares sold at $298.74 to $299.27. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote. 100% of the shares subject to the option shall vest on the earlier of the one year anniversary of the date of grant or the next Annual Meeting of Stockholders, subject to the Reporting Person's continued service as a director to the issuer. Non-statutory stock option granted pursuant to the Non-Employee Directors' Stock Option Plan. Option shall vest 100% one year after the date of grant or at the next Shareholders Meeting, whichever should take place first, provided that vesting will cease on termination of the Directors service to the Company. By: Donna Spinola For: Rubash, Mark J. 2023-04-24